Unione Europea - italiano - EMA (European Medicines Agency)

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - immunologici per suidi - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. un altro fattore chiave per la contaminazione del verro, lo skatole, può anche essere ridotto come effetto indiretto. anche i comportamenti aggressivi e sessuali (di montaggio) sono ridotti. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - neoplasie prostatiche - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Unione Europea - italiano - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degarelix - neoplasie prostatiche - terapia endocrina - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Unione Europea - italiano - EMA (European Medicines Agency)

n.v. organon - ganirelix - reproductive techniques, assisted; ovulation induction; infertility, female - ormoni ipofisari e ipotalamici e analoghi - la prevenzione dei picchi di ormone luteinizzante prematuri in donne sottoposte a iperstimolazione ovarica per tecniche di riproduzione assistita controllata. negli studi clinici, orgalutran è stato utilizzato con ricombinante umano ormone follicolo-stimolante o corifollitropin alfa, sostenuta follicolo stimolante.

Unione Europea - italiano - EMA (European Medicines Agency)

chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - ormoni ipofisari e ipotalamici e analoghi - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).

Italia - italiano - Ministero della Salute

fatro s.p.a. - buserelin acetato - buserelin acetato - 0 mg - buserelin

Unione Europea - italiano - EMA (European Medicines Agency)

n.v. organon - corifollitropina alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - ormoni sessuali e modulatori del sistema genitale, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).

Italia - italiano - Ministero della Salute

fatro s.p.a. - buserelin acetato - buserelin acetato - 0 mg - buserelin

Italia - italiano - Ministero della Salute

fatro s.p.a. - lecirelina - lecirelina - 25 mcg/ml, lecirelina - 25 mcg, lecirelina - 0.03 mg - lecirelin

Unione Europea - italiano - EMA (European Medicines Agency)

vetoquinol - triptorelin acetate - ormoni ipofisari e ipotalamici e analoghi - pigs (sows for reproduction) - for the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.